Uniqure NV (QURE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.67B
Last updated: Nov 17, 2026 at 11:06 AM ET
Uniqure NV (QURE) Stock Forecast
Analysts expect Uniqure NV (QURE) to earn -$3.33 per share in the fiscal year ending Dec 31, 2026, on revenue of $19.29M. Of 13 analysts, 11 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 4 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 13 ratings average 2.08, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 85% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 7.7% |
| Buy | 10 | 76.9% |
| Hold | 2 | 15.4% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 13
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 394.1%.
- Fiscal year ending Dec 31, 2026
- -$3.33
- EPS consensus, revenue $19.29M
- Fiscal year ending Dec 31, 2027
- -$2.64
- EPS consensus, revenue $95.32M
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$3.33 | -$3.47 to -$3.12 | 8 | $19.29M | $16.13M to $24.06M | 11 |
| Dec 31, 2027 | -$2.64 | -$3.83 to -$0.49 | 11 | $95.32M | $12.83M to $299.86M | 11 |
Quarterly Estimates
The EPS consensus falls from -$0.89 for the quarter ending Dec 31, 2026 to -$1.00 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.89 | -$1.60 to -$0.33 | 14 | $8.13M | $3.43M to $17.54M | 12 |
| Mar 31, 2027 | -$1.00 | -$1.39 to -$0.84 | 5 | $3.83M | $1.69M to $4.90M | 4 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 3 upward and 4 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 4 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$3.44.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$3.33 | -$3.44 | -$3.45 | -$3.43 | -$3.44 | N/A |
| Fiscal year ending Dec 31, 2027 | -$2.64 | -$2.64 | -$2.70 | -$2.63 | -$2.59 | N/A |
| Quarter ending Mar 31, 2027 | -$1.00 | -$1.04 | -$1.04 | -$1.03 | -$1.08 | N/A |
Frequently Asked Questions About QURE
What is the QURE stock forecast?
Consensus analyst estimates put Uniqure NV's EPS at -$3.33 for the fiscal year ending Dec 31, 2026, on revenue of $19.29M. The consensus rating from 13 analysts is Buy.
How do analysts rate QURE stock?
Of 13 analysts covering Uniqure NV, 1 rates it Strong Buy, 10 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from QURE next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.33, with estimates from -$3.47 to -$3.12 from 8 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.64, with estimates from -$3.83 to -$0.49 from 11 analysts.
What revenue do analysts expect from Uniqure NV next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $19.29M, with estimates from $16.13M to $24.06M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $95.32M, with estimates from $12.83M to $299.86M.
How many analysts cover QURE?
13 analysts rate Uniqure NV stock, and 8 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
QURE pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors